Inventor · disambiguated record
Zhenping Zhu
Also filed as: ZHU ZHENPING
19 granted patents·25 pending applications·221 citations·filing 2001–2023
92Inventor score
Files withSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD19KADMON CORP LLC9ZHU ZHENPING4IMCLONE LLC3IMCLONE SYSTEMS INC1
Top patents by PatentIndex Score
44 records- 0196US7598350B2Human anti-epidermal growth factor receptor antibodyIMCLONE LLC·Filed 2005·Granted Oct 6, 2009·73 cites·4 claims
- 0296US7498414B2Human antibodies specific to KDR and uses thereofIMCLONE SYSTEMS INC·Filed 2003·Granted Mar 3, 2009·98 cites·53 claims
- 0394US7740850B2PDGFRβ-specific antibodiesIMCLONE LLC·Filed 2008·Granted Jun 22, 2010·31 cites·6 claims
- 0488US12269886B2Tetravalent bispecific antibody against PD-1 and PD-L1SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2021·Granted Apr 8, 2025·2 cites·10 claims
- 0584US10407502B2Immunomodulatory agentsKADMON CORP LLC·Filed 2015·Granted Sep 10, 2019·7 cites·7 claims
- 0681US11667717B2Antibodies binding to human IL-4R, preparation method therefor and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted Jun 6, 2023·3 cites·12 claims
- 0778US8057791B2Human antibodies specific to KDR and uses thereofZHU ZHENPING·Filed 2008·Granted Nov 15, 2011·4 cites·4 claims
- 0876US2023338524A1Human Anti-VEGFR-2/KDR AntibodiesKADMON CORP LLC·Filed 2023·Application pending·0 cites
- 0970US2022127362A1Tetravalent bispecific antibody against pd-1/lag-3, preparation method therefor, and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1070US2022127360A1Tetravalent bispecific antibody against pd-1 and vegf, preparation method therefor, and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1170US2022127361A1TETRAVALENT BISPECIFIC ANTIBODY AGAINST PD-1/TGF-beta, PREPARATION METHOD THEREFOR, AND USE THEREOFSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1269US7393565B2Assembly of carbon tube-in-tube nanostructuresMAX PLANCK GESELLSCHAFT·Filed 2005·Granted Jul 1, 2008·3 cites·18 claims
- 1368US11633475B2Human anti-VEGFR-2/KDR antibodiesKADMON CORP LLC·Filed 2020·Granted Apr 25, 2023·0 cites·8 claims
- 1461US12509528B2Antibody binding to human CD38, preparation method thereof, and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2021·Granted Dec 30, 2025·0 cites·22 claims
- 1560US2024254232A1Trispecific antibody and preparation method therefor and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1659US2025129175A1CDC Platform AntibodySUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1759US2004259156A1Bispecific immunoglobulin-like antigen binding proteins and method of productionFiled 2004·Application pending·0 cites
- 1858US10588968B2Human anti-VEGFR-2/KDR antibodiesKADMON CORP LLC·Filed 2015·Granted Mar 17, 2020·0 cites·13 claims
- 1958US2025066499A1Antibody binding to human cd73, preparation method therefor, and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 2057US2022135686A1Antibody that binds to human pd-l1SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 2157US2025066508A1Anti-masp-2 antibody, preparation method therefor, and application thereofSHENYANG SUNSHINE PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2256US2023312682A1SIRPalpha-FC FUSION PROTEINSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 2355US2022259330A1Tetravalent bispecific antibody, preparation method therefor, and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 2454US2023399394A1Antibody Binding to Human IL-33, Preparation Method Therefor, and Use ThereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 2553US12351612B2Method for preparing recombinant human nerve growth factorSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2020·Granted Jul 8, 2025·0 cites·12 claims
- 2653US2024059775A9Immunomodulatory agentsKADMON CORP LLC·Filed 2020·Application pending·0 cites
- 2751US10364291B2Human anti-VEGFR-2/KDR antibodiesKADMON CORP LLC·Filed 2018·Granted Jul 30, 2019·0 cites·20 claims
- 2851US10023640B2Human anti-VEGFR-2/KDR antibodiesKADMON CORP LLC·Filed 2013·Granted Jul 17, 2018·0 cites·34 claims
- 2950US12319748B2Antibody binding to human HER2 and preparation method and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted Jun 3, 2025·0 cites·18 claims
- 3050US11370836B2Monoclonal antibody binding to human IL-5, preparation method therefor and use thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2018·Granted Jun 28, 2022·0 cites·19 claims
- 3150US2002103345A1Bispecific immunoglobulin-like antigen binding proteins and method of productionFiled 2001·Application pending·0 cites
- 3248US2023257465A1ANTI-PDL1 x EGFR BISPECIFIC ANTIBODYSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 3347US2004242851A1Bispecific antibodies that bind to vegf receptorsFiled 2002·Application pending·0 cites
- 3446US10125144B2Rho kinase inhibitorsKADMON CORP LLC·Filed 2014·Granted Nov 13, 2018·0 cites·8 claims
- 3546US2010221267A1Pdgfr beta-specific inhibitorsIMCLONE LLC·Filed 2010·Application pending·0 cites
- 3644US2010143371A1IntrabodiesZHU ZHENPING·Filed 2007·Application pending·0 cites
- 3743US11254746B2Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereofSUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2018·Granted Feb 22, 2022·0 cites·23 claims
- 3843US2005214860A1Antibodies specific to KDR and uses thereofZHU ZHENPING·Filed 2004·Application pending·0 cites
- 3943US2009028859A1Bispecific antibodies that bind to vegf receptorsZHU ZHENPING·Filed 2002·Application pending·0 cites
- 4042US12384853B2Anti-HER2/PD1 bispecific antibodySUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted Aug 12, 2025·0 cites·10 claims
- 4142US2002064528A1Antibodies specific to KDR and uses thereofFiled 2001·Application pending·0 cites
- 4241US2013245233A1Multispecific MoleculesLEI MING·Filed 2011·Application pending·0 cites
- 4339US2018244779A1Immunomodulatory agentsKADMON CORP LLC·Filed 2016·Application pending·0 cites
- 4426US2012195895A1Fusion Protein of an Anti-CD20 Antibody Fab Fragment and Lidamycin, a Method for Preparing the Same, and the Use ThereofYANG CHUNZHENG·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhenping Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →